{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-24-001372","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2024-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.391137+00:00","generated_at":"2026-05-31T05:25:59.215277+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Renovaro seeks strategic investors for up to 20% of subsidiary Cube","bullets":["Board intends to offer up to 20% ownership in RenovaroCube, a wholly owned molecular data science subsidiary.","Cube uses proprietary AI for multi-omics analysis to accelerate precision medicine, starting with cancer.","Proceeds from the offering expected to advance Cube's platform and go-to-market strategy.","Subscription terms to be determined as investors are identified and approved by Renovaro's Board.","RenovaroBio continues work on patented cancer vaccine targeting pancreatic, head and neck, liver tumors."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-24-001372","json":"https://secwatch.observer/filing/0001731122-24-001372.json","markdown":"https://secwatch.observer/filing/0001731122-24-001372.md","text":"https://secwatch.observer/filing/0001731122-24-001372.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001372/0001731122-24-001372-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001372/e5928_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:25:59.215277+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}